Scientific expertise.
Scalable innovation.
Tailored for you.
Through our Experiment-as-a-Service offering, you gain access to our specialized expertise, optimized protocols, and state-of-the-art facilities without the burden of in-house investment.
From disease modelling to drug testing, we're committed to removing barriers to discovery and ensuring every researcher can unlock the potential of ex vivo hematopoiesis research.
From the Lab to business impact
Whether you're investigating hematopoiesis, evaluating drug responses, or modeling rare blood disorders, our EaaS model offers tailored support from concept to data.
Learn more about the Science behind the Platform
Custom
Experimental Design
Collaborate with our scientific team to design experiments that fit your research goals using SilkInk® or our bone marrow bioreactor technologies.
End-to-End
Execution
We handle bioprinting, culture, and assay workflows in our controlled laboratory environment, ensuring consistency and reproducibility.
Real-Time Monitoring
& Analytics
Integrated biosensors and biochemical reporters enable non-destructive, real-time tracking of metabolic and functional cellular responses.
High-Content
Data Delivery
Receive rich datasets including imaging, molecular profiling, and functional readouts - ready for direct analysis or integration into your pipeline.
Scalable
High-Throughput Options
From pilot studies to high-throughput drug screening, we adapt to your scale and timeline.
Tell us about your project
Let’s work together to accelerate your research with human-relevant, silk-based platforms for drug discovery, disease modeling, and cell production.